Axatilimab (INCA034176), PREDNISONE, METHYLPREDNISOLONE, Jakavi 5 mg tablets
INCA34176-254
Phase 2 small_molecule active
Quick answer
Axatilimab (INCA034176), PREDNISONE, METHYLPREDNISOLONE, Jakavi 5 mg tablets for chronic graft-versus-host disease is a Phase 2 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- chronic graft-versus-host disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active